Provided by Tiger Trade Technology Pte. Ltd.

Syndax Pharmaceuticals

19.57
-0.0800-0.41%
Post-market: 19.570.00000.00%16:10 EDT
Volume:1.40M
Turnover:27.34M
Market Cap:1.75B
PE:-7.80
High:19.87
Open:19.70
Low:19.17
Close:19.65
52wk High:25.59
52wk Low:12.99
Shares:89.30M
Float Shares:80.30M
Volume Ratio:1.14
T/O Rate:1.74%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.5100
EPS(LYR):-3.2949
ROE:-255.93%
ROA:-18.67%
PB:115.74
PE(LYR):-5.94

Loading ...

BUZZ-U.S. STOCKS ON THE MOVE-UnitedHealth,  Pinterest, Celcuity

Reuters
·
Jun 04

BUZZ-Syndax Pharma slides after $250 mln convertible bond sale

Reuters
·
Jun 04

Syndax announces $250M convertible senior note offering due 2031

TIPRANKS
·
Jun 04

Syndax prices USD 250 million convertible senior notes due 2031

Reuters
·
Jun 04

Syndax Pharmaceuticals - to Issue $250 Mln of 2.25% Convertible Senior Notes Due 2031

THOMSON REUTERS
·
Jun 04

Press Release: Syndax Announces Private Placement of $250.0 Million of Convertible Senior Notes

Dow Jones
·
Jun 04

Top 20 US Stocks by Trading Volume on June 4: Marvell Technology Extends Rally to Five Days, Hitting Another Record High

Deep News
·
Jun 04

Syndax says revumenib post-transplant maintenance study shows 90% 2-year survival in acute leukemia patients

Reuters
·
Jun 03

Syndax Pharmaceuticals to host R&D Day spotlighting revumenib, axatilimab programs

Reuters
·
Jun 01

Syndax Pharmaceuticals Price Target Maintained With a $40.00/Share by HC Wainwright & Co.

Dow Jones
·
May 22

Analysts Offer Insights on Healthcare Companies: IN8bio (INAB), Syndax Pharmaceuticals (SNDX) and Olema Pharmaceuticals (OLMA)

TIPRANKS
·
May 22

Syndax revumenib post-transplant AML maintenance data wins ASCO 2026 oral slot

Reuters
·
May 22

Syndax Announces Four Revuforj® (Revumenib) Abstracts Accepted for Asco 2026, Including an Oral Presentation of Post-Transplant Data

THOMSON REUTERS
·
May 22

AI Hardware Crowded to Extreme Levels While Tech Giants Face Collective Underweighting

Deep News
·
May 20

Syndax CEO Metzger joins TD Cowen Oncology Innovation Summit fireside chat

Reuters
·
May 20

Broadcom's Market Cap Surpasses $2 Trillion for the First Time on May 15th

Deep News
·
May 15

20 Stocks in the S&P 500 of Companies with Soaring Sales and Improving Profit Margins

Dow Jones
·
May 14

Syndax Pharmaceuticals Is Maintained at Buy by UBS

Dow Jones
·
May 13

Syndax price target lowered to $37 from $38 at UBS

TIPRANKS
·
May 13

Syndax Pharmaceuticals (SNDX) Gets a Buy from UBS

TIPRANKS
·
May 13